中燃(00384.HK)与华新燃气订战略合作
中国燃气(00384.HK)公布,於昨日(10日)与华新燃气集团订立战略合作协议,双方将发挥各自优势,优化山西能源供给和消费结构,推动煤炭消费减量替代,加快山西燃气事业的发展。
根据协议,华新燃气将支持集团参与全省大气污染治理和燃煤替代改造工程,为煤改气项目协调供气工作,并积极配合政府有关部门逐步将集团燃气管网及终端工程纳入「散煤替代」、「清洁取暖」的任务范围。
中国燃气与华新燃气并计划加大投资力度,扩展城燃公司规模,透过现有合资公司继续开发山西省境内的农村「煤改气」、燃气发电、售电、分布式能源、液化石油气销售和加气站开发及运营项目,以及计划就完善山西省煤成气和天然气产供储销体系建设,适时推进组建公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.